Search research articles
Contact Us
Filters
Showing results (431-440 of 560) with videos related to
Page
of 56
Sort By:
Haematologica
|
August 24, 2014
A new prognostic score for AIDS-related lymphomas in the rituximab-era
Stefan K Barta, Xiaonan Xue, Dan Wang, et al.
Journal of the National Cancer Institute
|
June 5, 2014
Tumor microenvironment of metastasis and risk of distant metastasis of breast cancer
Thomas E Rohan, Xiaonan Xue, Hung-Mo Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 2, 2015
Clinical and Translational Results of a Phase II, Randomized Trial of an Anti-IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine Therapy
William J Gradishar, Denise A Yardley, Rachel Layman, et al.
The Lancet. Oncology
|
March 14, 2026
Deep learning on histopathological images to predict breast cancer recurrence risk and chemotherapy benefit: a multicentre, model development and validation study
Gil Shamai, Shachar Cohen, Yoav Binenbaum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 10, 2009
Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer
Joseph A Sparano, Lori J Goldstein, Barrett H Childs, et al.
International Journal of Molecular Sciences
|
September 23, 2022
Prognostic role of hERG1 Potassium Channels in Neuroendocrine Tumours of the Ileum and Pancreas
Jessica Iorio, Lorenzo Antonuzzo, Emanuela Scarpi, et al.
NPJ Breast Cancer
|
November 16, 2017
A metastasis biomarker (MetaSite <i>Breast</i>™ Score) is associated with distant recurrence in hormone receptor-positive, HER2-negative early-stage breast cancer
Joseph A Sparano, Robert Gray, Maja H Oktay, et al.
The Oncologist
|
February 22, 2017
Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast Cancer
Linda T Vahdat, Rachel Layman, Denise A Yardley, et al.
Journal of Geriatric Oncology
|
June 5, 2025
Assessing frailty in patients with relapsed/refractory multiple myeloma: A comparison between the patient-reported frailty phenotype and the International Myeloma Working Group frailty index
Daniela Krepper, Francesco Sparano, Johannes M Giesinger, et al.
Breast Cancer Research and Treatment
|
October 21, 2024
CYP2D6 activity in patients with metastatic breast cancer treated with single agent tamoxifen: results from ECOG-ACRIN E3108
Vered Stearns, Anne ONeill, Bryan P Schneider, et al.
Page
of 56
Search research articles
Search
Showing results (431-440 of 560) with videos related to
Sort By:
Page
of 56
Haematologica
|
August 24, 2014
A new prognostic score for AIDS-related lymphomas in the rituximab-era
Stefan K Barta, Xiaonan Xue, Dan Wang, et al.
Journal of the National Cancer Institute
|
June 5, 2014
Tumor microenvironment of metastasis and risk of distant metastasis of breast cancer
Thomas E Rohan, Xiaonan Xue, Hung-Mo Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 2, 2015
Clinical and Translational Results of a Phase II, Randomized Trial of an Anti-IGF-1R (Cixutumumab) in Women with Breast Cancer That Progressed on Endocrine Therapy
William J Gradishar, Denise A Yardley, Rachel Layman, et al.
The Lancet. Oncology
|
March 14, 2026
Deep learning on histopathological images to predict breast cancer recurrence risk and chemotherapy benefit: a multicentre, model development and validation study
Gil Shamai, Shachar Cohen, Yoav Binenbaum, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 10, 2009
Relationship between Topoisomerase 2A RNA Expression and Recurrence after Adjuvant Chemotherapy for Breast Cancer
Joseph A Sparano, Lori J Goldstein, Barrett H Childs, et al.
International Journal of Molecular Sciences
|
September 23, 2022
Prognostic role of hERG1 Potassium Channels in Neuroendocrine Tumours of the Ileum and Pancreas
Jessica Iorio, Lorenzo Antonuzzo, Emanuela Scarpi, et al.
NPJ Breast Cancer
|
November 16, 2017
A metastasis biomarker (MetaSite <i>Breast</i>™ Score) is associated with distant recurrence in hormone receptor-positive, HER2-negative early-stage breast cancer
Joseph A Sparano, Robert Gray, Maja H Oktay, et al.
The Oncologist
|
February 22, 2017
Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast Cancer
Linda T Vahdat, Rachel Layman, Denise A Yardley, et al.
Journal of Geriatric Oncology
|
June 5, 2025
Assessing frailty in patients with relapsed/refractory multiple myeloma: A comparison between the patient-reported frailty phenotype and the International Myeloma Working Group frailty index
Daniela Krepper, Francesco Sparano, Johannes M Giesinger, et al.
Breast Cancer Research and Treatment
|
October 21, 2024
CYP2D6 activity in patients with metastatic breast cancer treated with single agent tamoxifen: results from ECOG-ACRIN E3108
Vered Stearns, Anne ONeill, Bryan P Schneider, et al.
Page
of 56